NICE
NICE rejects arthritis drug Orencia
November 2, 2007Sales and Marketing NICE
NICE has rejected Orenica, a new treatment for rheumatoid arthritis, saying the drug is not a cost effective option for …
Eisai to appeal against Alzheimer’s court ruling
October 3, 2007Alzheimer's, Eisai, NICE
Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …
NICE approves MSD and Schering-Plough’s Ezetrol
September 14, 2007Sales and Marketing Inegy, NICE, cv
NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …
NICE to re-think blindness drugs decision
August 9, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …
Woman wins court battle for Avastin treatment
July 19, 2007Sales and Marketing NICE, avastin
A woman with bowel cancer has won her High Court battle for access to the drug Avastin, overturning a decision …
NICE set to block blindness drugs
June 15, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …
NICE in the dock: what the judicial review means for pharma
April 16, 2007Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review
The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
NICE to say no to Tarceva
November 17, 2006Sales and Marketing NICE, Tarceva
Roche's new lung cancer treatment Tarceva looks set to be refused recommendation from NICE.Tarceva (erlotinib) is the first next-generation treatment …
Pharma’s evolving relationship with NICE
November 1, 2006Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare
Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …
Head-to-head: Nice and the SMC
August 16, 2006Research and Development, Sales and Marketing NICE, SMC, healthcare
The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the Herceptin …
The way forward for clinical research
October 23, 2003Research and Development NICE, clinical research, healthcare
Clinical investigators in drug development have made enormous contributions to the advancement of healthcare over the last 25 years, and …
The management of schizophrenia
October 14, 2003Sales and Marketing NICE, clinical guidelines, healthcare, schizophrenia
The publication of NICE's clinical guidelines on the management of schizophrenia in December marks a significant milestone – the first …
